medline.ch Onkologie Gynäkologische Tumoren

	Comparative effectiveness and safety of adjuvant trastuzumab plus pertuzumab versus trastuzumab emtansine in HER2-positive breast cancer with residual disease after neoadjuvant therapy: a real-world retrospective study. Front Oncol Liu Z, Wang X, Gai J, Wang C, Yi X, Liu Y, Zhou T. PMID: 42434737 [PubMed - in process]
	Navigating specific targets of psychoneurological symptom cluster in breast cancer: a computer-simulated network analysis. Front Oncol Cai J, Liu Z, Liu X, Wan C, Duan X. PMID: 42434734 [PubMed]
	Examining the connection between BRCA1/2 mutations and uterine cancer: a comprehensive review. Ann Med Surg (Lond) Saleem SM, Nasir SAS, Nida F, Khalid M, Gandhi H, Javaid MH, Roy A. PMID: 42433835 [PubMed]
	"Immune senescence and dormant tumor cells: reconceptualizing breast cancer recurrence as an affliction of aging and chronic inflammation". Ann Med Surg (Lond) Amjad A, Benny O, Gharaee S, Ali U, Junaid M, Khalid M. PMID: 42433754 [PubMed]
	High-grade, poorly differentiated breast carcinoma mimicking primary breast lymphoma: a case report of a diagnostic dilemma. Ann Med Surg (Lond) Khadka S, Sapkota A, Regmi P, Shah R, Tiwari I, Thadarai D. PMID: 42433753 [PubMed]
	The value of multi-parametric ultrasonography nomogram in predicting nipple-areolar complex involvement in breast cancer. Quant Imaging Med Surg Ma Y, Tang S, Zhang J, Ma Y, Lian Q, Jin C, Lu J, Zhou P. PMID: 42433580 [PubMed]
	The value of non-enhanced magnetic resonance imaging based on T2-weighted imaging and apparent diffusion coefficient in the study of three-tiered HER2 status in patients with breast cancer. Quant Imaging Med Surg Chen W, Liu C, Li A, Wang X, Peng Y, Qin J, Liu W. PMID: 42433563 [PubMed]
	Metronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI-Integrated Future Strategies. Cancer Rep (Hoboken) Chauhan R, Das SK, Malhotra L, Goyal R, Mirza S, Nehra K, Merhi M, Al-Shabeeb Akil AS, Uddin S, Tripathi S, Bhat AA, Singh M. PMID: 42432987 [PubMed - in process]
	A novel diagnostic model for early-stage high-grade serous ovarian cancer based on serum tRNA-derived fragments. Cancer Biomark Zhao X, Wen W, Jia Y, Yuan L, Chen L, Liu S, Fan H, Jiang H, Pan C, Zhang C, Yao S. PMID: 42432867 [PubMed - in process]
	AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 Study. Cancer Sci Hamada K, Hamanishi J, Matsumura N, Ueda A, Takamatsu S, Yoshihara K, Nagasawa T, Seki T, Kikuchi A, Fujimoto E, Taki M, Yamanoi K, Murakami R, Kudo H, Oda K, Shimada M, Okamoto A, Mandai M. PMID: 42432821 [PubMed - as supplied by publisher]
	Home-based high-intensity exercise training during neoadjuvant chemotherapy is associated with favorable chemotherapy outcomes and tumor microenvironment remodeling in breast cancer. Cell Commun Signal Skorinkina D, Egl, Zayakin P, Mlynska A, Martin-Gracia B, Bassols-Citores E, Sadovska L, Brok, Rise F, Sagini K, Romero S, Gkelis K, Zablocka T, , Ce, K, Liepniece-Karele I, Egl, Silina K, Llorente A, Lin. PMID: 42432678 [PubMed - as supplied by publisher]
	Lower blood glucose levels (HbA1c) within the non-diabetic range are associated with improved survival in patients diagnosed with lung, colon and ovarian cancer: an explorative study. BMC Cancer Abrahamsen O, Schou JHV, Johansen JS, Jensen MB, Lykke J, Høgdall C, Budtz-Jørgensen E, Høgdall E. PMID: 42432556 [PubMed - as supplied by publisher]
	Association of tumor-infiltrating lymphocytes and proinflammatory biomarkers with breast cancer molecular subtypes: analysis of the MEND study. Breast Cancer Res Treat Byemerwa J, Neish D, Forgah L, Deveaux A, Osazuwa-Peters O, Joshi A, Salako O, Daramola A, Alatise O, Ogun G, Hall A, Adeniyi A, Ayandipo O, Olajide T, Olasehinde O, Arowolo O, Adisa A, Afuwape O, Olusanya A, Adegoke A, Tollefsbol TO, Arnett D, Muehlbauer MJ, Akinyemiju T. PMID: 42432165 [PubMed - in process]
	Lymphatic and Vascular Dual-System Super-Resolution Ultrasound for Diagnosing Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Study. Ultrasound Med Biol Li H, Wang H, Yao J, Cui S, Chang C, Deng M, Chen S, Zhang F. PMID: 42431777 [PubMed - as supplied by publisher]
	Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Locally Advanced Inoperable Breast Cancer- A Phase 2 Randomized Controlled Trial (NEOTRAC STUDY). Int J Radiat Oncol Biol Phys Iyer P, Krishnamurthy A, Velusamy S, Sundersingh S, Rajaram S, Venkatraman P, Varadarajan M, Gunasekaran M, Selvarajan G, Radhakrishnan V. PMID: 42431330 [PubMed - as supplied by publisher]
	Minimal Clinically Important Differences to Determine Meaningful Change in the Skin Symptom Assessment (SSA) Questionnaire for the Randomized Controlled Trial of Mepitel Film Versus Standard of Care for the Prevention of Acute and Chronic Dermatitis in Breast Cancer Radiation Treatment. Clin Breast Cancer Yang C, Tang L, Zhang L, Karam I, Lam J, Spadafora S, Chen H, Hircock C, Raman S, Lee SF, Wong HCY, Chow E. PMID: 42431149 [PubMed - as supplied by publisher]
	Tucatinib in Combination With Trastuzumab Deruxtecan in Patients With Previously Treated HER2+ Unresectable Locally Advanced or Metastatic Breast Cancer: An Open-Label Phase 2 Study. Clin Breast Cancer Modi S, Murthy RK, Chien AJ, Lin NU, McAndrew NP, Specht JM, Zelnak AB, Ramos J, Xie D, Ho J, Inoue JK, Carey LA, Hamilton EP. PMID: 42431148 [PubMed - as supplied by publisher]
	Local ablative treatment and continuation of systemic therapy for oligoprogressive metastatic breast cancer: a retrospective cohort study. Cancer Treat Res Commun Almekinders CAM, Snellen TIM, van Ommen-Nijhof A, Steenbruggen TG, Klompenhouwer EG, Kok NFM, Kuhlmann KFD, van Duijnhoven F, Bos MEMM, Wiersma TG, Dezentjé VO, Sonke GS. PMID: 42430886 [PubMed - as supplied by publisher]
	Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Oncol Res Treat He M, Zhu F, Jiang F, Liu Y, Guo Y, Yang Y, Jiang H, Xiong F, Cheng W, Xu Z, Liu B. PMID: 42430299 [PubMed - as supplied by publisher]
	Real-Time Integration of Patient-Reported Outcomes in Breast Cancer Surgery: Feasibility of the BREAST-Q REACT. Plast Reconstr Surg Gabay AJ, Abu El Hawa A, Boe L, Dinh-Do D, Rakauskas A, Kim M, Stern CS, Mehrara BJ, Tadros A, Nelson JA. PMID: 42430729 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 331957

Seite 1 von 16598

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung